CollPlant Biotechnologies Ltd. (CLGN)

NASDAQ: CLGN · USD

$4.11

+0.03 (+0.7%)· Recorded snapshot

Market cap	7.8M
Revenue (ttm)	318K
Net income (ttm)	-12.5M
EPS (ttm)	-$9.32
Shares out	1.9M
Volume	22,969.6
Beta	0.76

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 318K
Net income (ttm): -12.5M
EPS (ttm): -$9.32
Market cap: 7.8M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	보유

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-11-04 14:30 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-162

P25 n/aP50 n/aP75 n/a

ROIC-73.4

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All CLGN indicators

Market & fundamental data

Available fields

198

Groups with data

Currency

USD

Showing 198 of 198 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001631487
Company name	CollPlant Biotechnologies Ltd.
Country	Israel
Country code	US
CUSIP number	19516R107
Earnings date	2026-11-25
Earnings time	bmo
Employees	39
Employees change	-18
Employees growth	-31.58%
Enterprise value	$7.9M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2004
Industry	Biotechnology
Is primary listing	Yes
Is SPAC	No
ISIN number	IL0004960188
Last 10-K release date	2026-03-26
Last earnings date	2026-09-30
Last refreshed	2026-11-04
Last stock split date	2026-09-04
Last stock split type	Reverse
Market cap	$7.8M
Market cap category	Nano-Cap
Next earnings date	2026-11-25
Options	Yes
Price	$4.11
Price currency	USD
Sector	Healthcare
SIC code	3842
Stock price date	2026-11-03
Symbol	CLGN
Website	https://collplant.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-226.79%
EV/Sales	24.76x
FCF / EV yield	-143.35%
FCF yield	-145.21%
Forward EV/Sales	7.57x
Forward P/S	7.48x
P/B ratio	2.02x
P/S ratio	24.44x
Price / tangible book value	2.68x
Sector forward P/E	23.32x
Sector P/E	49.47x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Operating margin	-3,900.94%
Pretax margin	-3,934.91%
Profit per employee	$-320,846
Revenue per employee	$8,154
ROA	-62.95%
ROA (5Y)	-25.28%
ROCE	-263.32%
ROE	-161.98%
ROE (5Y)	-52.59%
ROIC	-73.36%
SBC / revenue	191.51%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	1
EPS growth years	1
Net income growth quarters	1
Net income growth years	1
Revenue growth	-86.76%
Revenue growth (Q)	-39.67%
Revenue growth (QoQ)	47.95%
Revenue growth 3Y	-69.11%
Revenue growth 5Y	-56.27%
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-91,000
Depreciation and amortization	$846,000
EBIT	$-12.4M
EBITDA	$-11.6M
EPS	$-9.32
FCF per share	$-5.97
Financing cash flow	$2.3M
Free cash flow	$-11.3M
Free cash flow minus SBC	$-11.9M
Gross profit	$-1M
Investing cash flow	$-8,000
Net cash flow	$-8.9M
Net income	$-12.5M
Operating cash flow minus SBC	$-11.8M
Operating income	$-12.4M
Revenue	$318,000
Stock-based compensation	$609,000

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-28.14
Book value per share	$2.04
Debt / equity	0.9
Interest coverage	-165.4
Long-term assets	$3.3M
Long-term liabilities	$1.8M
Net cash (debt)	$-101,000
Net cash / market cap	-1.3%
Net debt / equity	0.03
Piotroski F-Score	1
Property, plant and equipment	$3.2M
Shareholders' equity	$2.9M
Tangible book value	$2.9M
Tangible book value per share	$2.01
Total assets	$7.2M
Total cash	$2.6M
Total debt	$2.7M
Total liabilities	$4.3M
WACC	6.85%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.03
Current assets	$3.9M
Current liabilities	$2.5M
Current ratio	1.57
Inventory turnover	2.45
Net working capital	$-255,000
Quick ratio	1.19
Working capital	$1.4M
Working capital turnover	0.06

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-16.22%
Dividend yield	0%
Shareholder yield	-16.22%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$3.67
1D price change	0.74%
1M price change	18.79%
1M total return	18.79%
1W price change	5.39%
1W total return	5.39%
1Y price change	-80.97%
1Y return CAGR	-80.99%
1Y total return	-80.97%
20-day SMA	$3.86
200-day SMA	$5.00
3M price change	50.66%
3M total return	50.66%
3Y price change	-92.61%
3Y return CAGR	-58.02%
3Y total return	-92.61%
50-day SMA	$3.73
50-day SMA vs 200-day SMA	50under200
52-week high	$22.90
52-week high date	2025-11-03
52-week low	$2.64
52-week low date	2026-08-28
5Y price change	-98.13%
5Y return CAGR	-54.89%
5Y total return	-98.13%
6M price change	0.1%
6M total return	0.09%
After-hours change	2.19%
After-hours close	$4.11
After-hours price	$4.20
All-time high	$278.55
All-time high date	2015-08-11
All-time low	$2.64
All-time low date	2026-08-28
Average true range (ATR)	$0.41
Average volume	52K
Beta (1Y)	-0.52
Beta (2Y)	0.1
Beta (5Y)	0.76
Change from 52-week high	-82.05%
Change from 52-week low	55.86%
Change from all-time high	-98.52%
Change from all-time low	55.86%
Change from open	2.49%
Day's gap	-1.72%
Dollar volume	$94,405
High price	$4.44
Low price	$3.99
Monthly RSI	34.91
Open price	$4.01
Position in 52-week range	26.67%
Premarket change	6.08%
Premarket close	$4.11
Premarket price	$4.36
Previous close	$4.08
Price vs 150-day SMA	12.05%
Price vs 20-day SMA	6.59%
Price vs 200-day SMA	-17.75%
Price vs 50-day SMA	10.19%
Relative volume	0.44
RSI	55.6
Sharpe ratio	-0.83
Sharpe ratio (3Y)	-0.34
Sharpe ratio (5Y)	-0.39
Sortino ratio	-1.06
Sortino ratio (3Y)	-0.46
Sortino ratio (5Y)	-0.53
Volume	23K
Weekly RSI	43.09
YTD price change	-70.64%
YTD total return	-70.64%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1.1M
Float percentage	59.86%
Shares change (QoQ)	4.94%
Shares change (YoY)	16.22%
Shares held by insiders	40.14%
Shares held by institutions	8.76%
Shares outstanding	1.9M
Short % of shares	2.12%
Short ratio	0.7 days

Deeper analysis on CLGN

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this CLGN report

Is a complete CLGN research report available?

No complete published report is available for CollPlant Biotechnologies Ltd. (CLGN) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

CollPlant Biotechnologies Ltd. (CLGN)

Price

Financial snapshot

Fair-value bridge

Latest news · CLGN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CLGN indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CLGN

Frequently asked questions